Company intelligence / Profile preview

Aeneas Capital

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Aeneas Capital is an investment institution focused on co-creating, funding, and enabling start-ups and facilities in the healthcare and life sciences sectors, especially in partnership with Aptorum Group, Accelerate (ASTAR), and Pyrinas. It does not itself own or run clinical-stage drug/device programs but fosters ecosystems for such.

Industry: Investors

Partnerships

Aptorum Group Limited (biopharma)A*ccelerate Technologies Pte Ltd (commercial arm of A*STAR)Pyrinas Real Estate Management Limited

Beyond the preview

Go deeper on Aeneas Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aeneas Capital.

Explore the full profile